Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 11679986)

Published in Liver Transpl on October 01, 2001

Authors

J Figueras1, L Ibañez, E Ramos, E Jaurrieta, J Ortiz-de-Urbina, F Pardo, J Mir, C Loinaz, L Herrera, P López-Cillero, J Santoyo

Author Affiliations

1: Ciudad Sanitaria y Universitaria (CSU) Bellvitge, Barcelona, Spain. jfigueras@csub.scs.es

Articles citing this

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26

Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol (2010) 1.25

Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol (2011) 1.12

Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10

Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford) (2010) 1.05

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging (2013) 1.00

Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol (2007) 0.97

Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol (2015) 0.96

Hepatectomy as treatment of choice for hepatocellular carcinoma in elderly cirrhotic patients. World J Surg (2005) 0.90

The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci (2008) 0.89

Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.86

Current status of therapy for hepatocellular carcinoma. Therap Adv Gastroenterol (2009) 0.84

Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT). Cancer Imaging (2005) 0.83

Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. World J Gastroenterol (2007) 0.83

Current management of patients with hepatocellular carcinoma. World J Hepatol (2015) 0.82

Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. Int J Hepatol (2011) 0.82

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol (2013) 0.81

What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma? Liver Transpl (2011) 0.80

Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol (2015) 0.80

Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation. World J Gastroenterol (2014) 0.79

Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. World J Surg (2012) 0.78

Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant (2015) 0.78

Selection of patients with hepatocellular carcinoma for liver transplantation: Past and future. World J Hepatol (2016) 0.78

Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2011) 0.78

Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) (2012) 0.77

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? Langenbecks Arch Surg (2007) 0.77

Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway. Oncotarget (2015) 0.77

Surgical approach for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol (2015) 0.76

Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage. World J Gastroenterol (2008) 0.76

Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop. Can J Gastroenterol (2006) 0.75

Articles by these authors

A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med (1996) 3.44

The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage (2011) 3.17

Randomized clinical study of Gastrografin administration in patients with adhesive small bowel obstruction. Br J Surg (2003) 3.06

Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur J Biochem (1999) 2.99

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96

Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78

HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60

Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature. Catheter Cardiovasc Interv (2001) 2.49

The eIF-2alpha kinases and the control of protein synthesis. FASEB J (1996) 2.19

Stereotactic targeting of the globus pallidus internus in Parkinson's disease: imaging versus electrophysiological mapping. Neurosurgery (1999) 2.13

Role of resection and primary anastomosis of the left colon in the presence of peritonitis. Br J Surg (2000) 1.93

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology (1999) 1.76

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol (1987) 1.75

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology (2000) 1.72

Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg (2000) 1.65

The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation (2001) 1.63

The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology (1997) 1.62

Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol (1989) 1.53

Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leuk Res (2007) 1.52

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer (2000) 1.52

Repair of ventral hernias with expanded polytetrafluoroethylene patch. Br J Surg (1998) 1.50

Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg (2000) 1.49

Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg (1985) 1.46

Hyperlipidemia in liver transplant recipients: prevalence and risk factors. Liver Transpl Surg (1997) 1.46

Extra-anatomic venous graft for portal vein thrombosis in liver transplantation. Transpl Int (1997) 1.45

Morbidity and survival of liver resection for colorectal adenocarcinoma. Dis Colon Rectum (1991) 1.44

Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl (2001) 1.44

[Resistance of Mycobacterium tuberculosis in the province of Castellón]. Arch Bronconeumol (1996) 1.40

[In re the therapeutic aspects of the carcinoid syndrome]. Rev Esp Enferm Dig (1992) 1.39

Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence. Rev Esp Enferm Dig (2006) 1.39

[Correlation between magnetic resonance and disability scales (EDSS and ISS) in multiple sclerosis]. Neurologia (1991) 1.39

[HIV related Foix-Chavany-Marie syndrome]. Neurologia (2003) 1.39

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38

Liver transplantation in cirrhotic patients over 60 years of age. Rev Esp Enferm Dig (1998) 1.38

Endoscopy versus double-contrast barium enema in the evaluation of patients with symptoms suggestive of colorectal carcinoma. Am J Surg (1988) 1.38

[Liver transplantation in patients with HIV infection]. Gastroenterol Hepatol (2004) 1.38

Persistent pleural effusion and post-traumatic subarachnoidal-pleural fistula. Eur J Cardiothorac Surg (1991) 1.38

The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis (2011) 1.38

Risk of recurrent spontaneous abortion for pregnancies discovered in the fifth week of gestation. Lancet (1994) 1.37

Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis (1998) 1.34

Catheter sepsis due to Staphylococcus epidermidis during parenteral nutrition. Surg Gynecol Obstet (1980) 1.34

Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation (2001) 1.34

Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr (1985) 1.32

Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology (1997) 1.31

Müllerian defects in women with normal reproductive outcome. Fertil Steril (1991) 1.29

Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant (2001) 1.28

Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl (2000) 1.28

Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg (2001) 1.28

Human tuberculosis due to Mycobacterium bovis and M. caprae in Spain, 2004-2007. Int J Tuberc Lung Dis (2009) 1.27

Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl (2001) 1.25

A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. EMBO J (1989) 1.24

Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus. Vaccine (1998) 1.24

Liver transplantation in patients with portal vein thrombosis. Liver Transpl (2001) 1.23

Prognostic factors for mortality in left colonic peritonitis: a new scoring system. J Am Coll Surg (2000) 1.22

Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest (1995) 1.22

De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl (2001) 1.22

Liver resection of colorectal metastases in elderly patients. Br J Surg (2010) 1.21

Protection against Boophilus annulatus infestations in cattle vaccinated with the B. microplus Bm86-containing vaccine Gavac. off. Vaccine (1998) 1.19

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation (2001) 1.18

The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation (1996) 1.17

Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med (2005) 1.17

Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones. Horm Metab Res (2012) 1.17

Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg (1982) 1.16

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1993) 1.16

Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol (1994) 1.13

Normative data stratified by age and education for the Neuropsychological Screening Battery for Hispanics (NeSBHIS): Initial report. J Int Neuropsychol Soc (1996) 1.13

Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine (1997) 1.13

European Nutrition and Health Report 2009. Ann Nutr Metab (2009) 1.13

Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol (2007) 1.12

Intraoperative colonic lavage and primary anastomosis in peritonitis and obstruction. Br J Surg (1997) 1.11

HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet (1998) 1.11

31-year-old woman with an enlarged tender liver. Lancet (1995) 1.10

Bradycardia after rapid intravenous infusin of amphotericin B. Lancet (1993) 1.09

Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac. Genet Anal (1999) 1.08

Small bowel tumors: an overview. Dig Dis (1996) 1.08

Inappropriate antidiuretic hormone following adenine arabinoside administration. Antimicrob Agents Chemother (1979) 1.08

Adenocarcinoma of the appendix. Surg Gynecol Obstet (1988) 1.08

Osseous metastases from colorectal carcinoma. Am J Surg (1986) 1.08

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness. Br J Cancer (2008) 1.07

Vascular complications after orthotopic liver transplantation: hepatic artery thrombosis. Transplant Proc (2010) 1.07

Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABB). Ann Oncol (2004) 1.07

Hemiballism in Parkinson's disease. J Neurol Neurosurg Psychiatry (1995) 1.07

Psychosocial indexes and cardiovascular risk factors in a community sample. Psychother Psychosom (2000) 1.07

Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant (2013) 1.07

Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. Am Surg (1993) 1.06

Current status of the treatment of acute colonic diverticulitis: a systematic review. Colorectal Dis (2012) 1.06

A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res (2004) 1.05

Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients. Transpl Infect Dis (2006) 1.04